GB2021112A - Nitrofuryl-vinylene-thiazoles and oxazoles as antitumour agents - Google Patents

Nitrofuryl-vinylene-thiazoles and oxazoles as antitumour agents

Info

Publication number
GB2021112A
GB2021112A GB7917474A GB7917474A GB2021112A GB 2021112 A GB2021112 A GB 2021112A GB 7917474 A GB7917474 A GB 7917474A GB 7917474 A GB7917474 A GB 7917474A GB 2021112 A GB2021112 A GB 2021112A
Authority
GB
United Kingdom
Prior art keywords
nitrofuryl
vinylene
oxazoles
thiazoles
amidinohydrazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7917474A
Other versions
GB2021112B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of GB2021112A publication Critical patent/GB2021112A/en
Application granted granted Critical
Publication of GB2021112B publication Critical patent/GB2021112B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Certain nitrofuryl-vinylene compounds having the formula: <IMAGE> wherein R<1> and R<2> each independently represent hydrogen, (C1-C4) alkyl, (C1-C4) acyl, (C1-C4) alkoxycarbonyl, carboxyl, or (C1-C4) acyl wherein oxygen of the carbonyl group has been transformed into semicarbazone, thiosemicarbazone, amidinohydrazone, oxime or oxime-acetate, or R<1> and R<2> together with the carbon atoms to which they are bonded form a saturated or unsaturated five-membered or six-membered ring, and X represents oxygen or sulfur, or being an acid salt thereof when R<1> and/or R<2> represents amidinohydrazone, are provided for use in the treatment of cancers in mammals, particularly cancers of the digestive system and melanoma. The compounds may be administered in the form of a pharmaceutical composition including a pharmaceutically acceptable excipient.
GB7917474A 1978-05-19 1979-05-18 Nitrofuryl - ninylene - triazoles and oxazoles as antitumour agents Expired GB2021112B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5976078A JPS54163822A (en) 1978-05-19 1978-05-19 Antiitumor agent

Publications (2)

Publication Number Publication Date
GB2021112A true GB2021112A (en) 1979-11-28
GB2021112B GB2021112B (en) 1982-11-03

Family

ID=13122534

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7917474A Expired GB2021112B (en) 1978-05-19 1979-05-18 Nitrofuryl - ninylene - triazoles and oxazoles as antitumour agents

Country Status (6)

Country Link
JP (1) JPS54163822A (en)
CH (1) CH640851A5 (en)
DE (1) DE2920248A1 (en)
FR (1) FR2426053A1 (en)
GB (1) GB2021112B (en)
IT (1) IT1114244B (en)

Also Published As

Publication number Publication date
IT7922724A0 (en) 1979-05-16
IT1114244B (en) 1986-01-27
DE2920248A1 (en) 1979-11-22
FR2426053A1 (en) 1979-12-14
JPS54163822A (en) 1979-12-26
CH640851A5 (en) 1984-01-31
GB2021112B (en) 1982-11-03
JPS6136492B2 (en) 1986-08-19

Similar Documents

Publication Publication Date Title
SE7712693L (en) ORGANIC ASSOCIATIONS
JPS5632463A (en) Imidazole derivative* its manufacture and medicine as active component thereof
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
NO152047C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 5- (PARADEUTEROPHENYL) -5-PHENYL HYDANTOIN
DE3061693D1 (en) Secondary amines, their preparation and use in pharmaceutical compositions
SE7608203L (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED DIFENYL SULFIDES
NZ227082A (en) N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic acid; process for their preparation; and pharmaceutical compositions containing them
GB1550496A (en) 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications
GB2021112A (en) Nitrofuryl-vinylene-thiazoles and oxazoles as antitumour agents
ES8307224A1 (en) Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them.
ES471672A1 (en) Psychopharmacological peptides suitable for therapeutic administration
GB2021111A (en) Nitrofuryl-vinylene-thiazole N-oxides as antitumour agents
KR970704723A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents (DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS)
IE45200L (en) Pharmaceutical composition
ATE172959T1 (en) ACYLPHENYLGLYCINE DERIVATIVE AND PREVENTIVE AND CURE AGAINST DISEASES CAUSED BY INCREASED COLLAGENOSE ACTIVITY CONTAINING THIS AS AN ACTIVE INGREDIENT
BE881834A (en) DRUGS AND PHARMACEUTICAL PREPARATIONS WITH CYTOSTATIC ACTIVITY
DE2962856D1 (en) Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
JPS5536453A (en) Novel immunosuppressive agent
JPS5536454A (en) Novel immunosuppressive agent
ES469840A1 (en) Fused triazoles
ES467519A1 (en) Furoyl- and thenoyl-aryloxyalkyl carboxylic acid derivatives, their preparation and their use in therapy
GB2006196A (en) Phenylacetamides with analgesic activity
GB2007646A (en) 7 beta -Heterocyclic substituted imino-cephems

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee